Atlas Venture Life Science Advisors, LLC
Follow13F filer, CIK 1917529, CAMBRIDGE, MA
Atlas Venture Life Science Advisors, LLC reported $631,189,317 across 9 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-10.
Accepted , ingested 13F-HR 0001104659-26-125242
- Period
- 2026-09-30
- Reported value
- $631M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| OBXnew | +4,503,149 | $61.8M |
| ODTXnew | +2,692 | $59.8K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| DYNreduced | -3,359,379 | -$54.1M |
| IRONreduced | -129,850 | -$8.5M |
| KRROreduced | -189,624 | -$1.88M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001104659-26-125242, largest first. % of portfolio is the value over $631,189,317, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| KYMRKYMERA THERAPEUTICS INC | 2,847,541 | $318M | 50.43% | 0 | Timeline | ||
| IRONDISC MEDICINE INC | 1,384,025 | $90.6M | 14.35% | -129,850 | Timeline | ||
| OBXOBSIDIAN THERAPEUTICS INC | 4,503,149 | $61.8M | 9.8% | new | Timeline | ||
| KLRAKAILERA THERAPEUTICS INC | 5,171,282 | $59.1M | 9.36% | 0 | Timeline | ||
| DYNDYNE THERAPEUTICS INC | 3,440,720 | $55.4M | 8.78% | -3,359,379 | Timeline | ||
| QTTBQ32 BIO INC | 2,717,106 | $22.5M | 3.56% | 0 | Timeline | ||
| SIONSIONNA THERAPEUTICS INC | 2,995,602 | $15.8M | 2.5% | 0 | Timeline | ||
| KRROKORRO BIO INC | 773,260 | $7.66M | 1.21% | -189,624 | Timeline | ||
| ODTXODYSSEY THERAPEUTICS INC | 2,692 | $59.8K | 0.01% | new | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-26-125242 | base | 2026-11-10 |